Detalhe da pesquisa
1.
Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial.
JAMA
; 310(20): 2164-73, 2013 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24281461
2.
[Efficacy of meloxicam in juvenile polyposis syndrome. A case report]. / Poliposi giovanile in un caso clinico in cui e risultata efficace la terapia con meloxicam.
Pediatr Med Chir
; 31(2): 86-8, 2009.
Artigo
em Italiano
| MEDLINE | ID: mdl-19642502
3.
Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.
Inflamm Bowel Dis
; 21(8): 1739-49, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26185909
4.
Efficacy of meloxicam in a patient with juvenile polyposis syndrome.
J Pediatr Gastroenterol Nutr
; 48(5): 636-8, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19412013
5.
Impact of JC virus antibody testing in patients with Crohn's disease with loss of response to infliximab: a Markov model.
Inflamm Bowel Dis
; 19(12): 2625-33, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24108113
6.
Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab.
Arthritis Care Res (Hoboken)
; 63(4): 612-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21452272
7.
Current therapeutic approaches to autoimmune chronic uveitis in children.
Autoimmun Rev
; 9(10): 674-83, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20553975